PROTOCOL ACTIVATION
GENITOURINARY

NRG-GU006:
A Phase II, Double-Blinded, Placebo-Controlled Randomized Trial Of Salvage Radiotherapy With or Without Enhanced Anti-Androgen Therapy With Apalutamide in Recurrent Prostate Cancer, NCT # 03371719. Activation Date: April 27, 2018. 

Documents are posted to the CTSU website.

View this email in your browser
You are receiving this email because of your relationship with NRG Oncology. Please reconfirm your interest in receiving emails from us. If you do not wish to receive any more emails, you can unsubscribe here.
This message was sent from NRG-Broadcasts@NRGOncology.org to NRG-Broadcasts@NRGOncology.org
Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103


Update Profile/Email Address | Forward Email | Report Abuse